Oct 082015
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, CA – CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage biopharmaceutical company developing therapies to treat metabolic diseases with high unmet medical need, today announced that Robert J. Wills, Ph.D., a member of the Board of Directors since March 2015, has been appointed Chairman of the Board of Directors.… => more

CymaBay Therapeutics names Robert Wills as Chairman of its Board of Directors

From:: CymaBay Therapeutics names Robert Wills as Chairman of its Board of Directors

 Posted by at 9:01 pm

Sorry, the comment form is closed at this time.

%d bloggers like this: